Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World.
Pasello G, Lorenzi M, Scattolin D, Del Conte A, Cecere F, Pavan A, Macerelli M, Polo V, Pilotto S, Santarpia M, Cumerlato E, Da Ros V, Targato G, Bortolami A, Bonanno L, Ferro A, Dal Maso A, Frega S, Guarneri V.
Pasello G, et al. Among authors: bonanno l.
Oncologist. 2024 Jul 5;29(7):596-608. doi: 10.1093/oncolo/oyae043.
Oncologist. 2024.
PMID: 38520745
Free PMC article.